Alamgir, M. A., Javid, R. A., Hameed, A., & Mustafa, I. (2015). Gender difference in components of metabolic syndrome among patients of type 2 diabetes. Pakistan journal of medical sciences, 31(4), 886.
Alberti, K. G., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., et al. (2009). Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 120(16), 1640-1645.
Alberti, K. G., Zimmet, P., & Shaw, J. (2005). The metabolic syndrome--a new worldwide definition. Lancet, 366(9491), 1059-1062.
Aziz, I. A. (2020). PREVALENCE OF METABOLIC SYNDROME IN TYPE 2 DIABETES MELLITUS PATIENTS. International Journal of Scientific Research, 8(12).
Basol, G., Barutcuoglu, B., Cakir, Y., Ozmen, B., Parildar, Z., Kose, T., et al. (2011). Diagnosing metabolic syndrome in type 2 diabetic Turkish patients: comparison of AHA/NHLBI and IDF definitions. Bratisl Lek Listy, 112(5), 253-259.
Biadgo, B., Melak, T., Ambachew, S., Baynes, H. W., Limenih, M. A., Jaleta, K. N., et al. (2018). The Prevalence of Metabolic Syndrome and Its Components among Type 2 Diabetes Mellitus Patients at a Tertiary Hospital, Northwest Ethiopia. Ethiop J Health Sci, 28(5), 645-654.
Birarra, M. K., & Gelayee, D. A. (2018). Metabolic syndrome among type 2 diabetic patients in Ethiopia: a cross-sectional study. BMC Cardiovasc Disord, 18(1), 149.
DeBoer, M. D., Gurka, M. J., Golden, S. H., Musani, S. K., Sims, M., Vishnu, A., et al. (2017). Independent Associations Between Metabolic Syndrome Severity and Future Coronary Heart Disease by Sex and Race. J Am Coll Cardiol, 69(9), 1204-1205.
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005). The metabolic syndrome. Lancet, 365(9468), 1415-1428.
Expert Panel on Detection, E. (2001). Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, 285(19), 2486.
Ford, E. S. (2005). Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care, 28(7), 1769-1778.
Foroozanfar, Z. M., Najafipour, H. P., Khanjani, N. P. M., Bahrampour, A. P. M., & Ebrahimi, H. M. (2015). The Prevalence of Metabolic Syndrome According to Different Criteria and its Associated Factors in Type 2 Diabetic Patients in Kerman, Iran. Iran J Med Sci, 40(6), 522-525.
Galassi, A., Reynolds, K., & He, J. (2006). Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med, 119(10), 812-819.
Gebremeskel, G. G., Berhe, K. K., Belay, D. S., Kidanu, B. H., Negash, A. I., Gebreslasse, K. T., et al. (2019). Magnitude of metabolic syndrome and its associated factors among patients with type 2 diabetes mellitus in Ayder Comprehensive Specialized Hospital, Tigray, Ethiopia: a cross sectional study. BMC research notes, 12(1), 603.
Grundy, S. M. (2008). Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol, 28(4), 629-636.
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., et al. (2005). Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112(17), 2735-2752.
Gurka, M. J., Guo, Y., Filipp, S. L., & DeBoer, M. D. (2018). Metabolic syndrome severity is significantly associated with future coronary heart disease in Type 2 diabetes. Cardiovasc Diabetol, 17(1), 17.
Han, T. S., & Lean, M. E. (2016). A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM Cardiovasc Dis, 5, 2048004016633371.
Herath, H. M. M., Weerasinghe, N. P., Weerarathna, T. P., & Amarathunga, A. (2018). A Comparison of the Prevalence of the Metabolic Syndrome among Sri Lankan Patients with Type 2 Diabetes Mellitus Using WHO, NCEP-ATP III, and IDF Definitions. Int J Chronic Dis, 2018, 7813537.
Islam, S. M. S., Purnat, T. D., Phuong, N. T. A., Mwingira, U., Schacht, K., & Fröschl, G. (2014). Non‐Communicable Diseases (NCDs) in developing countries: a symposium report. Globalization and health, 10(1), 81.
Kastorini, C. M., Panagiotakos, D. B., Georgousopoulou, E. N., Laskaris, A., Skourlis, N., Zana, A., et al. (2016). Metabolic syndrome and 10-year cardiovascular disease incidence: The ATTICA study. Nutr Metab Cardiovasc Dis, 26(3), 223-231.
Kengne, A. P., Limen, S. N., Sobngwi, E., Djouogo, C. F., & Nouedoui, C. (2012). Metabolic syndrome in type 2 diabetes: comparative prevalence according to two sets of diagnostic criteria in sub-Saharan Africans. Diabetol Metab Syndr, 4(1), 22.
Khosravi-Boroujeni, H., Ahmed, F., Sadeghi, M., Roohafza, H., Talaei, M., Dianatkhah, M., et al. (2015). Does the impact of metabolic syndrome on cardiovascular events vary by using different definitions? BMC Public Health, 15, 1313.
Koehler, C., Ott, P., Benke, I., & Hanefeld, M. (2007). Comparison of the prevalence of the metabolic syndrome by WHO, AHA/NHLBI, and IDF definitions in a German population with type 2 diabetes: the Diabetes in Germany (DIG) Study. Horm Metab Res, 39(9), 632-635.
Legato, M. J., Gelzer, A., Goland, R., Ebner, S. A., Rajan, S., Villagra, V., et al. (2006). Gender-specific care of the patient with diabetes: review and recommendations. Gender medicine, 3(2), 131-158.
Lin, S. X., & Pi-Sunyer, E. X. (2007). Prevalence of the metabolic syndrome among US middle-aged and older adults with and without diabetes--a preliminary analysis of the NHANES 1999-2002 data. Ethn Dis, 17(1), 35-39.
Misra, A., & Khurana, L. (2008). Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab, 93(11 Suppl 1), S9-30.
Nsiah, K., Shang, V. O., Boateng, K. A., & Mensah, F. O. (2015). Prevalence of metabolic syndrome in type 2 diabetes mellitus patients. Int J Appl Basic Med Res, 5(2), 133-138.
O'Neill, S., & O'Driscoll, L. (2015). Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev, 16(1), 1-12.
Ogedengbe, S. O., & Ezeani, I. U. (2014). Profile of metabolic abnormalities seen in patients with type 2 diabetes mellitus and their first degree relatives with metabolic syndrome seen in Benin City, Edo state Nigeria. Journal of Diabetes & Metabolic Disorders, 13(1), 61.
Ogurtsova, K., da Rocha Fernandes, J., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N. H., et al. (2017). IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes research and clinical practice, 128, 40-50.
Osei-Yeboah, J., Owiredu, W. K., Norgbe, G. K., Yao Lokpo, S., Gyamfi, J., Alote Allotey, E., et al. (2017). The Prevalence of Metabolic Syndrome and Its Components among People with Type 2 Diabetes in the Ho Municipality, Ghana: A Cross-Sectional Study. Int J Chronic Dis, 2017, 8765804.
Pokharel, D. R., Khadka, D., Sigdel, M., Yadav, N. K., Acharya, S., Kafle, R. C., et al. (2014). Prevalence of metabolic syndrome in Nepalese type 2 diabetic patients according to WHO, NCEP ATP III, IDF and Harmonized criteria. J Diabetes Metab Disord, 13(1), 104.
Rassool, G. H. (2003). Expert report on diet, nutrition and prevention of chronic diseases. J Adv Nurs, 43(6), 544-545.
Shin, J. A., Lee, J. H., Lim, S. Y., Ha, H. S., Kwon, H. S., Park, Y. M., et al. (2013). Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness. J Diabetes Investig, 4(4), 334-343.
Shulman, G. I. (2000). Cellular mechanisms of insulin resistance. The Journal of clinical investigation, 106(2), 171-176.
Song, S. H., & Hardisty, C. A. (2008). Diagnosing metabolic syndrome in type 2 diabetes: does it matter? QJM, 101(6), 487-491.
Tan, M. C., Ng, O. C., Wong, T. W., Joseph, A., Chan, Y. M., & Hejar, A. R. (2013). Prevalence of metabolic syndrome in type 2 diabetic patients: a comparative study using WHO, NCEP ATP III, IDF and Harmonized definitions. Health, 2013.
WHO. (2018). Noncommunicable diseases country profiles 2018.
Wube, T. B., Nuru, M. M., & Anbese, A. T. (2019). A Comparative Prevalence Of Metabolic Syndrome Among Type 2 Diabetes Mellitus Patients In Hawassa University Comprehensive Specialized Hospital Using Four Different Diagnostic Criteria. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 12, 1877.
Yadav, D., Mahajan, S., Subramanian, S. K., Bisen, P. S., Chung, C. H., & Prasad, G. B. (2013). Prevalence of metabolic syndrome in type 2 diabetes mellitus using NCEP-ATPIII, IDF and WHO definition and its agreement in Gwalior Chambal region of Central India. Glob J Health Sci, 5(6), 142-155.
Zimmet, P., Magliano, D., Matsuzawa, Y., Alberti, G., & Shaw, J. (2005). The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb, 12(6), 295-300.